Related Experiment Videos
Management of digitalis therapy in a primary care area
K Boman1, L Weinehall, J E Ogren
1Department of Internal Medicine, Skellefteå Hospital, Sweden.
Insights
Digitalis therapy requires clear indications and documented effectiveness. Many patients lacked defined heart disease or poorly documented treatment efficacy, highlighting the need for optimized cardiac glycoside use.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Digitalis, also known as cardiac glycosides, is widely prescribed.
- Optimizing its use in primary care is crucial for patient outcomes.
Purpose of the Study:
- To evaluate the appropriateness of digitalis therapy in a primary care setting.
- To assess indications for treatment and underlying heart conditions in patients receiving digitalis.
Main Methods:
- Retrospective study of 323 patients on digitalis therapy.
- Analysis of prescription data from Skellefteå health district, representing 90% of patients on digitalis.
- Scrutiny of treatment indications and documented heart diseases.
Main Results:
- One-third of patients had no defined underlying heart disease.
- Treatment effectiveness was poorly documented in approximately half of the patients.
- Identified variability in digitalis prescription practices.
Conclusions:
- Clear definition of indications for digitalis therapy is essential.
- Regular evaluation of treatment effectiveness is necessary for optimizing cardiac glycoside use.
- Improved documentation and patient selection can enhance digitalis therapy outcomes.
Abstract:
A retrospective study of 323 patients on digitalis therapy was performed in the primary care area of Skellefteå health district with the highest prescription of cardiac glycosides. The study comprised 90% of all patients on digitalis. Indications for treatment and the underlying heart disease were especially scrutinized. In one-third of all patients no underlying heart disease was defined and in about half of them the effectiveness of treatment was poorly documented. The study underlines the importance of defining the indication for treatment combined with a subsequent careful evaluation of the therapy in order to optimize treatment with cardiac glycosides.